Design Therapeutics DSGN
NASDAQ DSGN
$10.25 -0.24 (-2.29%)
As of: Oct 23, 2026 · 2:17 PM EDT

Design Therapeutics (DSGN) Net Preferred Shares Issued and Repurchased (2021)

Updated

Analysis

Design Therapeutics (DSGN) Net Preferred Shares Issued and Repurchased (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,127.42 Bn 1,096.00 Bn 19.71 Bn -
2 Johnson & Johnson 633.77 Bn 553.63 Bn 17.30 Bn -
3 AbbVie 505.19 Bn 478.30 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -
5 Novartis Ag 290.00 Bn 253.99 Bn 11.24 Bn -
6 Astrazeneca 265.19 Bn 238.88 Bn 12.86 Bn -
7 Amgen 238.02 Bn 193.42 Bn 7.24 Bn -
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn -
10 Design Therapeutics 640.05 Mn -215.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 124.71 Mn
API Access

Design Therapeutics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=DSGN&period=max&api_key=YOUR_API_KEY